CN101381389A - Chemical Synthesis of 5,7-Diene Steroids - Google Patents
Chemical Synthesis of 5,7-Diene Steroids Download PDFInfo
- Publication number
- CN101381389A CN101381389A CNA2008101214430A CN200810121443A CN101381389A CN 101381389 A CN101381389 A CN 101381389A CN A2008101214430 A CNA2008101214430 A CN A2008101214430A CN 200810121443 A CN200810121443 A CN 200810121443A CN 101381389 A CN101381389 A CN 101381389A
- Authority
- CN
- China
- Prior art keywords
- formula
- hydrazone
- diene
- organic solvent
- hour
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000003786 synthesis reaction Methods 0.000 title claims description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- 150000007857 hydrazones Chemical class 0.000 claims abstract description 32
- 239000003960 organic solvent Substances 0.000 claims abstract description 28
- 238000001953 recrystallisation Methods 0.000 claims abstract description 10
- 239000012467 final product Substances 0.000 claims abstract description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 138
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 60
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 42
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 40
- 238000010992 reflux Methods 0.000 claims description 30
- 239000002904 solvent Substances 0.000 claims description 28
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- 239000003513 alkali Substances 0.000 claims description 17
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000012043 crude product Substances 0.000 claims description 9
- 238000010189 synthetic method Methods 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- QARVLSVVCXYDNA-UHFFFAOYSA-N bromobenzene Chemical compound BrC1=CC=CC=C1 QARVLSVVCXYDNA-UHFFFAOYSA-N 0.000 claims description 4
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 claims description 4
- -1 p-toluenesulfonyl Chemical group 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000008096 xylene Substances 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 3
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 3
- YTZKOQUCBOVLHL-UHFFFAOYSA-N tert-butylbenzene Chemical compound CC(C)(C)C1=CC=CC=C1 YTZKOQUCBOVLHL-UHFFFAOYSA-N 0.000 claims description 3
- WQONPSCCEXUXTQ-UHFFFAOYSA-N 1,2-dibromobenzene Chemical compound BrC1=CC=CC=C1Br WQONPSCCEXUXTQ-UHFFFAOYSA-N 0.000 claims description 2
- OCJBOOLMMGQPQU-UHFFFAOYSA-N 1,4-dichlorobenzene Chemical compound ClC1=CC=C(Cl)C=C1 OCJBOOLMMGQPQU-UHFFFAOYSA-N 0.000 claims description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- 125000004423 acyloxy group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 229940117389 dichlorobenzene Drugs 0.000 claims description 2
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 150000002170 ethers Chemical class 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- 229910052744 lithium Chemical group 0.000 claims description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 2
- 239000011591 potassium Chemical group 0.000 claims description 2
- 229910052700 potassium Inorganic materials 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 238000009413 insulation Methods 0.000 claims 5
- 125000006239 protecting group Chemical group 0.000 claims 3
- QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 claims 2
- 239000003921 oil Substances 0.000 claims 2
- 238000010792 warming Methods 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 1
- 125000006309 butyl amino group Chemical group 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000001308 synthesis method Methods 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 70
- 239000000047 product Substances 0.000 description 43
- 239000007787 solid Substances 0.000 description 43
- 238000002844 melting Methods 0.000 description 42
- 230000008018 melting Effects 0.000 description 42
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 39
- 235000012000 cholesterol Nutrition 0.000 description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 26
- 239000000243 solution Substances 0.000 description 21
- 239000002585 base Substances 0.000 description 13
- 238000010907 mechanical stirring Methods 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- 238000010511 deprotection reaction Methods 0.000 description 11
- 150000001993 dienes Chemical class 0.000 description 11
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 10
- 239000007810 chemical reaction solvent Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 5
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000007256 debromination reaction Methods 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- HOPRXXXSABQWAV-UHFFFAOYSA-N anhydrous collidine Natural products CC1=CC=NC(C)=C1C HOPRXXXSABQWAV-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000018678 bone mineralization Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- UTBIMNXEDGNJFE-UHFFFAOYSA-N collidine Natural products CC1=CC=C(C)C(C)=N1 UTBIMNXEDGNJFE-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- AFRJJFRNGGLMDW-UHFFFAOYSA-N lithium amide Chemical compound [Li+].[NH2-] AFRJJFRNGGLMDW-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- ASSTXQFQQJYCIW-UHFFFAOYSA-N lithium;tert-butylazanide Chemical compound [Li+].CC(C)(C)[NH-] ASSTXQFQQJYCIW-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 238000006552 photochemical reaction Methods 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- GFYHSKONPJXCDE-UHFFFAOYSA-N sym-collidine Natural products CC1=CN=C(C)C(C)=C1 GFYHSKONPJXCDE-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Landscapes
- Steroid Compounds (AREA)
Abstract
本发明公开了一种式(I)所示的5,7-双烯甾类化合物的合成方法,所述的合成方法包括如下步骤:先将式(II)所示的腙和式(III)所示的碱在-20~50℃于有机溶剂中反应0~6小时,然后升温到25~150℃,保温反应0.5~6小时,反应液经去保护基处理后回收溶剂得到粗品,粗品经重结晶得到最终产物5,7-双烯甾类化合物。本发明反应条件温和、反应收率高(一般在85%以上,甚至能达到95%以上)、生产成本低、选择性好,是一条先进的工艺路线。
The invention discloses a method for synthesizing 5,7-diene steroids represented by formula (I). The synthesis method comprises the following steps: firstly combining hydrazone represented by formula (II) with formula (III) The base shown is reacted in an organic solvent at -20-50°C for 0-6 hours, then heated up to 25-150°C, and kept for 0.5-6 hours. Recrystallization gave the final product 5,7-diene steroids. The present invention has mild reaction conditions, high reaction yield (generally above 85%, even above 95%), low production cost and good selectivity, and is an advanced process route.
Description
(一)技术领域 (1) Technical field
本发明涉及一种5,7-双烯甾类化合物的化学合成方法。The invention relates to a chemical synthesis method of 5,7-diene steroids.
(二)背景技术 (2) Background technology
5,7-双烯甾类化合物是维生素D类药物的前体,广泛应用于医药、食品、农药、化工等领域,具有很高的实用价值。维生素D类药物的主要作用是调节钙、磷的代谢,促进肠内钙、磷的吸收和骨质钙化,维持血钙和血磷的平衡,是人与动物生长、发育、繁殖、维持生命和保持健康必不可少的维生素。5,7-diene steroids are the precursors of vitamin D drugs, which are widely used in medicine, food, pesticide, chemical industry and other fields, and have high practical value. The main function of vitamin D drugs is to regulate the metabolism of calcium and phosphorus, promote the absorption of calcium and phosphorus in the intestine and bone calcification, and maintain the balance of blood calcium and blood phosphorus. Essential vitamins for good health.
在本发明作出之前,原有技术5,7-双烯甾类化合物的化学合成方法大多以5-烯-7-溴甾类化合物为原料经过脱溴得到5,7-双烯甾类化合物,比如在Bu4N+F-,三甲基吡啶(WO2008089093,US2571330)等体系中脱溴得到5,7-双烯甾类化合物,该方法收率偏低,大概在30-50%,污染严重。5,7-双烯甾类化合物还可从7-亚砜基取代物出发经消除反应得到(J.Org.Chem.,1981,46,1030;Tetrahedron Lett.,1991,32,5171;US20080171728)收率中等;也可以从7-酯基取代物经贵金属Pd催化或加热高温消除反应得到(Tetrahedron Lett.,1992,33,2549;J.Am.Chem.Soc.,1952,74,3318),该方法使用价格昂贵的Pd催化剂,成本较高。此外,上述方法还会产生某些无法除去的杂质,严重影响维生素D类药物合成中的光化反应。Before the present invention was made, most of the chemical synthesis methods of prior art 5,7-diene steroids used 5-ene-7-bromo steroids as raw materials to obtain 5,7-diene steroids through debromination, For example, debromination in Bu 4 N + F-, collidine (WO2008089093, US2571330) and other systems to obtain 5,7-diene steroids, the yield of this method is low, about 30-50%, and the pollution is serious . 5,7-diene steroids can also be obtained from 7-sulfoxide substituents through elimination reactions (J.Org.Chem., 1981, 46, 1030; Tetrahedron Lett., 1991, 32, 5171; US20080171728) The yield is medium; it can also be obtained from the 7-ester substituent by noble metal Pd catalysis or high-temperature elimination reaction by heating (Tetrahedron Lett., 1992, 33, 2549; J.Am.Chem.Soc., 1952, 74, 3318), This method uses the expensive Pd catalyst, and the cost is relatively high. In addition, the above method will also produce some impurities that cannot be removed, which will seriously affect the photochemical reaction in the synthesis of vitamin D drugs.
(三)发明内容 (3) Contents of the invention
本发明要解决的技术问题是提供一种工艺合理、选择性好、反应收率高、生产成本低、环境友好的5,7-双烯甾类化合物的化学合成方法。The technical problem to be solved by the present invention is to provide a chemical synthesis method of 5,7-diene steroids with reasonable process, good selectivity, high reaction yield, low production cost and environmental friendliness.
为解决上述技术问题,本发明用腙和碱来制备5,7-双烯甾类化合物,具体技术方案如下:In order to solve the problems of the technologies described above, the present invention uses hydrazone and alkali to prepare 5,7-diene steroids, and the specific technical scheme is as follows:
一种式(I)所示的5,7-双烯甾类化合物的合成方法,其特征在于所述的合成方法为:式(II)所示的腙和式(III)所示的碱在有机溶剂中反应,反应液经后处理得到最后产物5,7-双烯甾类类化合物(I);A kind of synthetic method of 5,7-diene steroids shown in formula (I), it is characterized in that described synthetic method is: the hydrazone shown in formula (II) and the base shown in formula (III) React in an organic solvent, and the reaction solution obtains the final product 5,7-diene steroid compound (I) through aftertreatment;
式(I)、式(II)或式(III)中,R1选自氢或C1~C8的酰基;R2选自苯磺酰基、对甲苯磺酰基或甲磺酰基;R3选自氢、羟基或酰氧基(酯基);R4选自C1~C6的烷基、C1~C6的烷氧基、氨基、二异丙基氨基、叔丁基氨基或氢;M为钠、钾或锂。In formula (I), formula (II) or formula (III), R 1 is selected from hydrogen or C1~C8 acyl; R 2 is selected from benzenesulfonyl, p-toluenesulfonyl or methanesulfonyl; R 3 is selected from hydrogen , hydroxyl or acyloxy group (ester group); R4 is selected from C1~C6 alkyl, C1~C6 alkoxy, amino, diisopropylamino, tert-butylamino or hydrogen; M is sodium, potassium or lithium.
反应式如下:The reaction formula is as follows:
进一步,所述合成方法优选按照如下步骤进行:先将式(II)所示的腙和式(III)所示的碱在-20~50℃于有机溶剂溶中反应0~6小时,然后升温到25~150℃,保温反应0.5~6小时,反应液经去保护基处理后回收溶剂得到粗品,粗品经重结晶后得到最后产物5,7-双烯甾类化合物;所述式(II)所示的腙和式(III)所示的碱的投料物质的量比推荐为1:1.0~6.0,所述有机溶剂的总质量用量为式(II)所示的腙质量的2~30倍。式(III)所示的碱可以以固体形式加入,也可以先用有机溶剂溶解,然后再加入反应体系。优选先用有机溶剂溶解碱,再加入反应体系。Further, the synthesis method is preferably carried out according to the following steps: first react the hydrazone represented by formula (II) and the base represented by formula (III) in an organic solvent solution at -20-50°C for 0-6 hours, and then heat up to 25-150°C, heat preservation reaction for 0.5-6 hours, the reaction solution is treated with deprotection group and the solvent is recovered to obtain the crude product, and the crude product is recrystallized to obtain the final product 5,7-diene steroid compound; the formula (II) The amount ratio of the hydrazone shown and the base shown in the formula (III) is recommended to be 1:1.0-6.0, and the total mass dosage of the organic solvent is 2 to 30 times the mass of the hydrazone shown in the formula (II) . The base represented by formula (III) can be added in solid form, or can be dissolved in an organic solvent first, and then added to the reaction system. It is preferred to first dissolve the base with an organic solvent, and then add it to the reaction system.
本发明在反应物投料完毕后,优选先在-20~20℃保温反应0.5~3小时,然后升温到50~120℃,保温反应1~3小时,所得反应液再进行去保护基处理。In the present invention, after the feeding of the reactants is completed, it is preferred to first heat-preserve and react at -20-20°C for 0.5-3 hours, then raise the temperature to 50-120°C, heat-preserve and react for 1-3 hours, and the resulting reaction solution is then subjected to deprotection group treatment.
所述的去保护基处理推荐为:反应液中加入水或醇以及去保护试剂,升温至回流温度充分反应除去保护基。优选的去保护试剂为下述之一:氢氧化钠、氢氧化钾、氢氧化锂,去保护试剂摩尔用量为腙摩尔数的0.01~2.0倍,优选为0.1~1.5倍。加入水或醇的用量没有特殊要求。The recommended deprotection group treatment is: add water or alcohol and a deprotection reagent to the reaction solution, and raise the temperature to reflux temperature to fully react and remove the protection group. The preferred deprotection reagent is one of the following: sodium hydroxide, potassium hydroxide, lithium hydroxide, and the molar amount of the deprotection reagent is 0.01-2.0 times, preferably 0.1-1.5 times, the mole number of hydrazone. There is no special requirement for the amount of water or alcohol added.
去保护基处理后进行回收溶剂处理:当在前述去保护基处理中加入水和去保护试剂时,需先静置分层后取有机相用无水硫酸钠干燥,然后再蒸去溶剂得到粗品。当在去保护基处理中加入醇和去保护试剂时,在回收溶剂步骤可直接蒸去溶剂。Recovering solvent treatment after deprotection group treatment: When water and deprotection reagent are added in the above deprotection group treatment, it is necessary to stand and separate first, then take the organic phase and dry it with anhydrous sodium sulfate, and then evaporate the solvent to obtain the crude product . When alcohol and a deprotecting reagent are added in the deprotecting group treatment, the solvent can be distilled off directly in the solvent recovery step.
本发明所述的有机溶剂可以是下式一种或两种以上按任意比例的组合:①C4~C12的烷烃,②C6~C12的芳烃类,③C2~C18的醚类。The organic solvent of the present invention can be one of the following formulas or a combination of two or more in any proportion: ① C4-C12 alkanes, ② C6-C12 aromatics, ③ C2-C18 ethers.
具体地说,所述的有机溶剂为下式一种或两种以上按任意比例的组合:己烷、石油醚、苯、甲苯、二甲苯、异丙苯、叔丁苯、氯苯、溴苯、二氯苯、二溴苯、硝基苯、乙醚、丙醚、异丙醚、丁醚、四氢呋喃、2-甲基四氢呋喃、苯甲醚。Specifically, the organic solvent is a combination of one or more of the following formulas in any proportion: hexane, petroleum ether, benzene, toluene, xylene, cumene, tert-butylbenzene, chlorobenzene, bromobenzene , Dichlorobenzene, dibromobenzene, nitrobenzene, ethyl ether, propyl ether, isopropyl ether, butyl ether, tetrahydrofuran, 2-methyltetrahydrofuran, anisole.
优选的有机溶剂为下述之一或下述任意几种按任意比例的组合:①己烷、②石油醚、③苯甲醚、④2-甲基四氢呋喃、⑤甲苯、⑥二甲苯、⑦氯苯、⑧硝基苯、⑨四氢呋喃。Preferred organic solvent is one of the following or any combination of any of the following in any proportion: 1. hexane, 2. petroleum ether, 3. anisole, 4. 2-methyltetrahydrofuran, 5. toluene, 6. xylene, 7. chlorobenzene , ⑧nitrobenzene, ⑨tetrahydrofuran.
优选的重结晶溶剂为下述之一或下述任意几种按任意比例的混合:甲苯、正己烷、环己烷、丙酮、环己酮、乙醚、石油醚、甲醇、乙醇。当采用混合溶液进行重结晶时,混合溶液各组分的相对体积比没有特别要求。The preferred recrystallization solvent is one of the following or a mixture of any of the following in any proportion: toluene, n-hexane, cyclohexane, acetone, cyclohexanone, ether, petroleum ether, methanol, ethanol. When the mixed solution is used for recrystallization, the relative volume ratio of the components of the mixed solution is not particularly required.
所述腙和碱的投料物质的量比推荐为1:1.0~6.0,优选1:1.0~3.0。所使用的有机溶剂的总质量用量为式(II)所示的腙质量的2~30倍,优选5~10倍。如果式(III)所示的碱在加入反应前先用有机溶剂溶解,则有机溶剂的总质量包括用来溶解腙和用来溶解碱的有机溶剂的总和,用来溶解式(III)所示的碱的有机溶剂的量以能够溶解式(III)所示的碱即可。The molar ratio of the hydrazone to the base is recommended to be 1:1.0-6.0, preferably 1:1.0-3.0. The total mass amount of the organic solvent used is 2 to 30 times, preferably 5 to 10 times, the mass of the hydrazone represented by formula (II). If the base shown in formula (III) is dissolved with an organic solvent before adding to the reaction, the total mass of the organic solvent includes the sum of the organic solvents used to dissolve the hydrazone and the base, used to dissolve the organic solvent shown in the formula (III) The amount of the organic solvent of the base can dissolve the base shown in formula (III).
具体推荐所述的合成方法按照如下步骤进行:先将式(II)所示的腙和式(III)所示的碱分别用有机溶剂溶解,然后维持温度在-20~20℃将碱的有机溶剂溶液加入到式(II)所示的腙的有机溶剂溶液中,维持温度反应0.5~3小时,缓慢升温到50~120℃,保温反应1~3小时,反应液加入水或醇以及去保护试剂,升温至回流温度反应0.1~2小时,用酸调节pH到7左右,回收溶剂得到粗品,粗品经重结晶得到最后产物5,7-双烯甾类化合物;所述式(II)所示的腙、式(III)所示的碱和去保护试剂的投料物质的量比为1:1.0~3.0:0.1~1.5,所述有机溶剂的总质量用量为式(II)所示的腙质量的5~10倍;所述去保护试剂为下列之一:氢氧化钠、氢氧化钾、氢氧化锂。It is specifically recommended that the synthetic method be carried out in accordance with the following steps: first dissolve the hydrazone shown in formula (II) and the base shown in formula (III) with an organic solvent respectively, and then maintain the temperature at -20 to 20°C to dissolve the organic solvent of the base. The solvent solution is added to the organic solvent solution of the hydrazone shown in formula (II), the temperature is maintained for 0.5 to 3 hours, the temperature is slowly raised to 50 to 120°C, the temperature is kept for 1 to 3 hours, and water or alcohol is added to the reaction solution and deprotected Reagent, heat up to reflux temperature and react for 0.1 to 2 hours, adjust the pH to about 7 with acid, recover the solvent to obtain the crude product, and the crude product is recrystallized to obtain the final product 5,7-diene steroid compound; said formula (II) The molar ratio of the hydrazone, the base shown in formula (III) and the deprotection reagent is 1:1.0~3.0:0.1~1.5, and the total mass consumption of the organic solvent is the mass of hydrazone shown in formula (II) 5-10 times; the deprotection reagent is one of the following: sodium hydroxide, potassium hydroxide, lithium hydroxide.
本发明所述合成方法制得的产品5,7-双烯甾类化合物收率可达85%以上。The yield of the product 5,7-diene steroid compound prepared by the synthesis method of the invention can reach more than 85%.
本发明与原有技术相比,优势体现在:Compared with the prior art, the present invention has the following advantages:
1.反应收率高(一般在85%以上,甚至能达到95%以上)、生产成本低;1. The reaction yield is high (generally above 85%, even can reach above 95%), and the production cost is low;
2.工艺路线先进、反应条件温和;2. Advanced process route and mild reaction conditions;
3.选择性好,基本无重排副产物。3. Good selectivity, basically no rearrangement by-products.
(四)具体实施方式 (4) Specific implementation methods
下面结合具体实施例对本发明作进一步说明,但本发明的保护范围不限于此。The present invention will be further described below in conjunction with specific examples, but the protection scope of the present invention is not limited thereto.
实施例1Example 1
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对甲苯磺酰腙100mmol(61g),用甲苯400mL溶解,降温至-20℃,加入甲基锂(6.6g,300mmol)的甲苯(50mL)溶液,维持温度在-20℃,反应0.5小时,然后升温至25℃搅拌2小时。反应完毕,加水100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,静置分层后有机相用无水硫酸钠干燥,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇36.1g,为浅黄色固体,熔点145-146℃,收率94%。In a 1000ml four-neck flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61g) of 3-acetoxycholesterol-7-p-toluenesulfonylhydrazone, dissolve it in 400mL of toluene, cool to -20°C, add A solution of methyl lithium (6.6 g, 300 mmol) in toluene (50 mL) was maintained at -20°C, reacted for 0.5 hour, then raised to 25°C and stirred for 2 hours. After the reaction is complete, add 100 mL of water and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, leave the organic phase to dry with anhydrous sodium sulfate after standing for layers, and evaporate the solvent. Recrystallization with ethanol/toluene gave 36.1 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 94%.
实施例2Example 2
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对甲苯磺酰腙100mmol(61g),用甲苯400mL溶解,降温至-20℃,加入甲基锂(6.6g,300mmol)的甲苯(50mL)溶液,维持温度在-20℃,反应0.5小时,然后升温至25℃搅拌2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇36.6g,为浅黄色固体,熔点145-146℃,收率95%。In a 1000ml four-neck flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61g) of 3-acetoxycholesterol-7-p-toluenesulfonylhydrazone, dissolve it in 400mL of toluene, cool to -20°C, add A solution of methyl lithium (6.6 g, 300 mmol) in toluene (50 mL) was maintained at -20°C, reacted for 0.5 hour, then raised to 25°C and stirred for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 36.6 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 95%.
实施例3Example 3
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对甲苯磺酰腙100mmol(61g),用甲苯400mL溶解,降温至-20℃,加入甲基锂(6.6g,300mmol)的甲苯(50mL)溶液,维持温度在-20℃,反应0.5小时,然后升温至25℃搅拌2小时。反应完毕,加乙醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇36.6g,为浅黄色固体,熔点145-146℃,收率95%。In a 1000ml four-neck flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61g) of 3-acetoxycholesterol-7-p-toluenesulfonylhydrazone, dissolve it in 400mL of toluene, cool to -20°C, add A solution of methyl lithium (6.6 g, 300 mmol) in toluene (50 mL) was maintained at -20°C, reacted for 0.5 hour, then raised to 25°C and stirred for 2 hours. After the reaction is complete, add 100 mL of ethanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 36.6 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 95%.
实施例4Example 4
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-苯磺酰腙100mmol(59.6g),用甲苯400mL溶解,降温至-20℃,加入甲基锂(6.6g,300mmol)的甲苯(50mL)溶液,维持温度在-20℃,反应0.5小时,然后升温至25℃搅拌2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇35.3g,为浅黄色固体,熔点145-146℃,收率92%。In a 1000ml four-necked flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (59.6g) of 3-acetoxycholesterol-7-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to -20°C, add A solution of methyl lithium (6.6 g, 300 mmol) in toluene (50 mL) was maintained at -20°C, reacted for 0.5 hour, then raised to 25°C and stirred for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 35.3 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 92%.
实施例5Example 5
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-甲磺酰腙100mmol(53.4g),用甲苯400mL溶解,降温至-20℃,加入甲基锂(6.6g,300mmol)的甲苯(50mL)溶液,维持温度在-20℃,反应0.5小时,然后升温至25℃搅拌2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇32.3g,为浅黄色固体,熔点145-146℃,收率84%。In a 1000ml four-necked flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (53.4g) of 3-acetoxycholesterol-7-methanesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to -20°C, add A solution of methyl lithium (6.6 g, 300 mmol) in toluene (50 mL) was maintained at -20°C, reacted for 0.5 hour, then raised to 25°C and stirred for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 32.3 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 84%.
实施例6Example 6
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至0℃,加入氨基锂(6.9g,300mmol)的甲苯(50mL)溶液,维持温度在0℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇27.3g,为浅黄色固体,熔点145-146℃,收率71%。In a 1000ml four-necked flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 0°C, and add A solution of lithium amide (6.9 g, 300 mmol) in toluene (50 mL) was maintained at 0° C. for 0.5 hours, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 27.3 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 71%.
实施例7Example 7
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至0℃,加入二异丙基氨基锂(32.1g,300mmol)的甲苯(50mL)溶液,维持温度在0℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇30.0g,为浅黄色固体,熔点145-146℃,收率78%。In a 1000ml four-necked flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 0°C, and add A solution of lithium diisopropylamide (32.1 g, 300 mmol) in toluene (50 mL) was maintained at 0° C. for 0.5 hours, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 30.0 g of dienyl cholesterol is a light yellow solid with a melting point of 145-146°C and a yield of 78%.
实施例8Example 8
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至0℃,加入叔丁基氨基锂(23.7g,300mmol)的甲苯(50mL)溶液,维持温度在0℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇32.6g,为浅黄色固体,熔点145-146℃,收率85%。In a 1000ml four-necked flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 0°C, and add A solution of lithium tert-butylamide (23.7 g, 300 mmol) in toluene (50 mL) was maintained at 0° C. for 0.5 hours, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 32.6 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 85%.
实施例9Example 9
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至20℃,加入甲醇钠(16.2g,300mmol)的甲苯(50mL)溶液,维持温度在20℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇29.2g,为浅黄色固体,熔点145-146℃,收率76%。In a 1000ml four-neck flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 20°C, add A solution of sodium methoxide (16.2 g, 300 mmol) in toluene (50 mL) was maintained at 20° C. for 0.5 hour, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 29.2 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 76%.
实施例10Example 10
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至20℃,加入乙醇钠(20.4g,300mmol)的甲苯(50mL)溶液,维持温度在20℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇28.4g,为浅黄色固体,熔点145-146℃,收率74%。In a 1000ml four-neck flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 20°C, add A solution of sodium ethoxide (20.4 g, 300 mmol) in toluene (50 mL) was maintained at 20° C., reacted for 0.5 hour, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 28.4 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 74%.
实施例11Example 11
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至20℃,加入叔丁醇钾(33.6g,300mmol)的甲苯(50mL)溶液,维持温度在20℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇30.7g,为浅黄色固体,熔点145-146℃,收率80%。In a 1000ml four-neck flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 20°C, add A solution of potassium tert-butoxide (33.6 g, 300 mmol) in toluene (50 mL) was maintained at 20° C. for 0.5 hour, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 30.7 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 80%.
实施例12Example 12
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至0℃,加入氢化钠(7.2g,300mmol)的甲苯(50mL)溶液,维持温度在0℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇34.6g,为浅黄色固体,熔点145-146℃,收率90%。In a 1000ml four-necked flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 0°C, and add A solution of sodium hydride (7.2 g, 300 mmol) in toluene (50 mL) was maintained at 0° C. for 0.5 hours, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 34.6 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 90%.
实施例13Example 13
在装有温度计、回流冷凝管和机械搅拌的1000ml四口烧瓶内,加入3-乙酰氧基胆固醇-7-对苯磺酰腙100mmol(61.0g),用甲苯400mL溶解,降温至0℃,加入氢化锂(2.4g,300mmol)的甲苯(50mL)溶液,维持温度在0℃,反应0.5小时,然后升温至110℃反应2小时。反应完毕,加甲醇100mL充分搅拌,加入氢氧化钠4g,升温至回流,反应30分钟,用盐酸或醋酸调至PH=7,蒸去溶剂,用乙醇/甲苯重结晶得到目标产品5,7-双烯胆固醇33.4g,为浅黄色固体,熔点145-146℃,收率87%。In a 1000ml four-necked flask equipped with a thermometer, reflux condenser and mechanical stirring, add 100mmol (61.0g) of 3-acetoxycholesterol-7-p-benzenesulfonylhydrazone, dissolve it in 400mL of toluene, cool down to 0°C, and add A solution of lithium hydride (2.4 g, 300 mmol) in toluene (50 mL) was maintained at 0° C. for 0.5 hours, and then heated to 110° C. for 2 hours. After the reaction is complete, add 100 mL of methanol and stir thoroughly, add 4 g of sodium hydroxide, heat up to reflux, react for 30 minutes, adjust the pH to 7 with hydrochloric acid or acetic acid, evaporate the solvent, and recrystallize with ethanol/toluene to obtain the target product 5,7- 33.4 g of Diene Cholesterol is a light yellow solid with a melting point of 145-146° C. and a yield of 87%.
实施例14Example 14
反应溶剂为2-甲基四氢呋喃,其它操作同实施例2,得到目标产品5,7-双烯胆固醇35.3g,为浅黄色固体,熔点145-146℃,收率92%。The reaction solvent was 2-methyltetrahydrofuran, and other operations were the same as in Example 2 to obtain 35.3 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 92%.
实施例15Example 15
反应溶剂为四氢呋喃,其它操作同实施例2,得到目标产品5,7-双烯胆固醇34.9g,为浅黄色固体,熔点145-146℃,收率91%。The reaction solvent was tetrahydrofuran, and other operations were the same as in Example 2 to obtain 34.9 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 91%.
实施例16Example 16
反应溶剂为正己烷,其它操作同实施例2,得到目标产品5,7-双烯胆固醇31.5g,为浅黄色固体,熔点145-146℃,收率82%。The reaction solvent was n-hexane, and other operations were the same as in Example 2 to obtain 31.5 g of the target product 5,7-diene cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 82%.
实施例17Example 17
反应溶剂为石油醚,其它操作同实施例2,得到目标产品5,7-双烯胆固醇33.4g,为浅黄色固体,熔点145-146℃,收率87%。The reaction solvent was petroleum ether, and other operations were the same as in Example 2 to obtain 33.4 g of the target product 5,7-diene cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 87%.
实施例18Example 18
反应溶剂为苯甲醚,其它操作同实施例2,得到目标产品5,7-双烯胆固醇36.1g,为浅黄色固体,熔点145-146℃,收率94%。The reaction solvent was anisole, and other operations were the same as in Example 2 to obtain 36.1 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 94%.
实施例19Example 19
反应溶剂为氯苯,其它操作同实施例2,得到目标产品5,7-双烯胆固醇33.8g,为浅黄色固体,熔点145-146℃,收率88%。The reaction solvent was chlorobenzene, and other operations were the same as in Example 2 to obtain 33.8 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 88%.
实施例20Example 20
反应溶剂为二甲苯,其它操作同实施例2,得到目标产品5,7-双烯胆固醇35.7g,为浅黄色固体,熔点145-146℃,收率93%。The reaction solvent was xylene, and other operations were the same as in Example 2 to obtain 35.7 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 93%.
实施例21Example 21
反应溶剂为硝基苯,其它操作同实施例2,得到目标产品5,7-双烯胆固醇34.9g,为浅黄色固体,熔点145-146℃,收率91%。The reaction solvent was nitrobenzene, and other operations were the same as in Example 2 to obtain 34.9 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 91%.
实施例22Example 22
加碱温度为-20℃,反应1小时,然后升温至50℃反应2小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇33.0g,为浅黄色固体,熔点145-146℃,收率86%。Add alkali at -20°C, react for 1 hour, then raise the temperature to 50°C and react for 2 hours, and other operations are the same as in Example 2 to obtain 33.0 g of the target product 5,7-diene cholesterol, which is a light yellow solid with a melting point of 145-146 °C, yield 86%.
实施例23Example 23
加碱温度为-20℃,反应1小时,然后升温至100℃反应2小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇33.8g,为浅黄色固体,熔点145-146℃,收率88%。Add alkali at -20°C, react for 1 hour, then raise the temperature to 100°C and react for 2 hours, and other operations are the same as in Example 2 to obtain 33.8 g of the target product 5,7-diene cholesterol, which is a light yellow solid with a melting point of 145-146 °C, yield 88%.
实施例24Example 24
加碱温度为0℃,反应1小时,然后升温至50℃反应2小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇31.1g,为浅黄色固体,熔点145-146℃,收率81%。Add alkali at 0°C, react for 1 hour, then raise the temperature to 50°C and react for 2 hours, and other operations are the same as in Example 2 to obtain 31.1 g of the target product 5,7-diene cholesterol, which is a light yellow solid with a melting point of 145-146°C , yield 81%.
实施例25Example 25
加碱温度为0℃,反应1小时,然后升温至100℃反应2小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇32.6g,为浅黄色固体,熔点145-146℃,收率85%。Add alkali at 0°C, react for 1 hour, then raise the temperature to 100°C and react for 2 hours, and other operations are the same as in Example 2 to obtain 32.6 g of the target product 5,7-diene cholesterol, which is a light yellow solid with a melting point of 145-146°C , yield 85%.
实施例26Example 26
加碱温度为20℃,反应1小时,然后升温至100℃反应2小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇29.2g,为浅黄色固体,熔点145-146℃,收率76%。Add alkali at 20°C, react for 1 hour, then raise the temperature to 100°C and react for 2 hours, and other operations are the same as in Example 2 to obtain 29.2 g of the target product 5,7-diene cholesterol, which is a light yellow solid with a melting point of 145-146°C , yield 76%.
实施例27Example 27
加碱温度为50℃,反应1小时,然后升温至100℃反应2小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇26.9g,为浅黄色固体,熔点145-146℃,收率70%。Add alkali at a temperature of 50°C, react for 1 hour, then raise the temperature to 100°C and react for 2 hours, and other operations are the same as in Example 2 to obtain 26.9 g of the target product 5,7-diene cholesterol, which is a light yellow solid with a melting point of 145-146°C , yield 70%.
实施例28Example 28
溶剂为苯甲醚,加碱温度为-20℃,反应1小时,然后升温至150℃反应6小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇37.6g,为浅黄色固体,熔点145-146℃,收率98%。The solvent is anisole, the temperature of adding alkali is -20°C, react for 1 hour, then raise the temperature to 150°C and react for 6 hours, other operations are the same as in Example 2, and 37.6g of the target product 5,7-diene cholesterol is obtained, which is light yellow Solid, melting point 145-146°C, yield 98%.
实施例29Example 29
溶剂为苯甲醚,加碱温度为50℃,反应1小时,然后升温至150℃反应6小时,其它操作同实施例2,得到目标产品5,7-双烯胆固醇36.5g,为浅黄色固体,熔点145-146℃,收率95%。The solvent is anisole, the temperature of adding alkali is 50°C, react for 1 hour, then raise the temperature to 150°C and react for 6 hours, other operations are the same as in Example 2, and 36.5g of the target product 5,7-dienylcholesterol is obtained as a light yellow solid , melting point 145-146°C, yield 95%.
实施例30Example 30
碱用量为200mmol(2.0当量),其它操作同实施例2,得到目标产品5,7-双烯胆固醇30.7g,为浅黄色固体,熔点145-146℃,收率80%。The amount of alkali used was 200 mmol (2.0 equivalents), and other operations were the same as in Example 2 to obtain 30.7 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 80%.
实施例31Example 31
碱用量为400mmol(4.0当量),其它操作同实施例2,得到目标产品5,7-双烯胆固醇36.1g,为浅黄色固体,熔点145-146℃,收率94%。The amount of alkali used was 400 mmol (4.0 equivalents), and other operations were the same as in Example 2 to obtain 36.1 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 94%.
实施例32Example 32
重结晶溶剂为石油醚/甲苯,其它操作同实施例2,得到目标产品5,7-双烯胆固醇33.1g,为浅黄色固体,熔点145-146℃,收率86%。The recrystallization solvent was petroleum ether/toluene, and other operations were the same as in Example 2 to obtain 33.1 g of the target product 5,7-diene cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 86%.
实施例33Example 33
重结晶溶剂为丙酮/甲醇,其它操作同实施例2,得到目标产品5,7-双烯胆固醇33.8g,为浅黄色固体,熔点145-146℃,收率88%。The recrystallization solvent was acetone/methanol, and other operations were the same as in Example 2 to obtain 33.8 g of the target product 5,7-dienyl cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 88%.
实施例34Example 34
重结晶溶剂为正己烷/乙醇,其它操作同实施例2,得到目标产品5,7-双烯胆固醇30.7g,为浅黄色固体,熔点145-146℃,收率80%。The recrystallization solvent was n-hexane/ethanol, and other operations were the same as in Example 2 to obtain 30.7 g of the target product 5,7-diene cholesterol as a light yellow solid with a melting point of 145-146° C. and a yield of 80%.
实施例35Example 35
底物腙为3-苯甲酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(67.2g),其它操作同实施例2,得到目标产品5,7-双烯胆固醇34.6g,为浅黄色固体,熔点145-146℃,收率90%。The substrate hydrazone is 3-benzoyloxycholesterol-7-p-toluenesulfonylhydrazone, and the feeding amount is 100mmol (67.2g). Other operations are the same as in Example 2 to obtain the target product 5,7-dienylcholesterol 34.6g, It is a light yellow solid with a melting point of 145-146°C and a yield of 90%.
实施例36Example 36
底物腙为3-对甲基苯甲酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(68.6g),其它操作同实施例2,得到目标产品5,7-双烯胆固醇34.9g,为浅黄色固体,熔点145-146℃,收率91%。The substrate hydrazone is 3-p-tolyloxycholesterol-7-p-toluenesulfonylhydrazone, and the feeding amount is 100mmol (68.6g). Other operations are the same as in Example 2 to obtain the target product 5,7-dienylcholesterol 34.9 g, as light yellow solid, melting point 145-146°C, yield 91%.
实施例37Example 37
底物腙为3-丙酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(62.4g),其它操作同实施例2,得到目标产品5,7-双烯胆固醇34.6g,为浅黄色固体,熔点145-146℃,收率90%。The substrate hydrazone is 3-propionyloxycholesterol-7-p-toluenesulfonylhydrazone, and the feeding amount is 100mmol (62.4g). Other operations are the same as in Example 2 to obtain the target product 5,7-dienylcholesterol 34.6g, which is Light yellow solid, melting point 145-146°C, yield 90%.
实施例38Example 38
底物腙为3-丁酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(63.8g),其它操作同实施例2,得到目标产品5,7-双烯胆固醇35.3g,为浅黄色固体,熔点145-146℃,收率92%。The substrate hydrazone is 3-butyryloxycholesterol-7-p-toluenesulfonylhydrazone, and the feeding amount is 100mmol (63.8g). Other operations are the same as in Example 2 to obtain the target product 5,7-dienylcholesterol 35.3g, which is Light yellow solid, melting point 145-146°C, yield 92%.
实施例39Example 39
底物腙为3-三氯乙酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(71.4g),其它操作同实施例2,得到目标产品5,7-双烯胆固醇33.8g,为浅黄色固体,熔点145-146℃,收率88%。The substrate hydrazone is 3-trichloroacetoxycholesterol-7-p-toluenesulfonylhydrazone, and the feeding amount is 100mmol (71.4g). Other operations are the same as in Example 2 to obtain the target product 5,7-dienylcholesterol 33.8g, It is a light yellow solid with a melting point of 145-146°C and a yield of 88%.
实施例40Example 40
底物腙为3,25-二乙酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(66.9g),氢氧化钠用量为8g,其它操作同实施例2,得到目标产品25-羟基-5,7-双烯胆固醇38.0g,为浅黄色固体,熔点175-176℃,收率95%。The substrate hydrazone is 3,25-diacetoxycholesterol-7-p-toluenesulfonyl hydrazone, the feeding amount is 100mmol (66.9g), the amount of sodium hydroxide is 8g, other operations are the same as in Example 2, and the target product 25- 38.0 g of hydroxy-5,7-diene cholesterol is a light yellow solid with a melting point of 175-176°C and a yield of 95%.
实施例41Example 41
底物腙为3,25-二苯甲酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(79.2g),氢氧化钠用量为8g,其它操作同实施例2,得到目标产品25-羟基-5,7-双烯胆固醇37.2g,为浅黄色固体,熔点175-176℃,收率93%。The substrate hydrazone is 3,25-dibenzoyloxycholesterol-7-p-toluenesulfonylhydrazone, the feeding amount is 100mmol (79.2g), the amount of sodium hydroxide is 8g, other operations are the same as in Example 2, and the target product is obtained 37.2 g of 25-hydroxy-5,7-diene-cholesterol is a light yellow solid with a melting point of 175-176 °C and a yield of 93%.
实施例42Example 42
底物腙为3-乙酰氧基-25-苯甲酰氧基胆固醇-7-对甲苯磺酰腙,投料量为100mmol(73.0g),氢氧化钠用量为8g,其它操作同实施例2,得到目标产品25-羟基-5,7-双烯胆固醇36.8g,为浅黄色固体,熔点175-176℃,收率92%。The substrate hydrazone is 3-acetoxy-25-benzoyloxycholesterol-7-p-toluenesulfonyl hydrazone, the feeding amount is 100mmol (73.0g), the sodium hydroxide consumption is 8g, and other operations are the same as in Example 2, 36.8 g of the target product 25-hydroxy-5,7-diene cholesterol was obtained as a light yellow solid with a melting point of 175-176° C. and a yield of 92%.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101214430A CN101381389B (en) | 2008-09-29 | 2008-09-29 | Chemical Synthesis of 5,7-Diene Steroids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101214430A CN101381389B (en) | 2008-09-29 | 2008-09-29 | Chemical Synthesis of 5,7-Diene Steroids |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101381389A true CN101381389A (en) | 2009-03-11 |
CN101381389B CN101381389B (en) | 2011-05-25 |
Family
ID=40461459
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101214430A Active CN101381389B (en) | 2008-09-29 | 2008-09-29 | Chemical Synthesis of 5,7-Diene Steroids |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101381389B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104910231A (en) * | 2015-05-18 | 2015-09-16 | 浙江工业大学 | 25-hydroxy-7-dehydrocholesterol synthetic method |
CN105131071A (en) * | 2015-07-14 | 2015-12-09 | 浙江花园生物高科股份有限公司 | Synthesis method of 25-hydroxycholesteryl acetate-7-p-toluenesulfonylhydrazone |
CN105646632A (en) * | 2016-01-19 | 2016-06-08 | 浙江新和成股份有限公司 | Method for preparing 7-dehydrogenized cholesteryl ester from 7-tosylhydrazones-3-cholesteryl ester |
CN112707779A (en) * | 2020-12-26 | 2021-04-27 | 蚌埠中实化学技术有限公司 | Preparation method of vinyl cyclohexane |
WO2021213988A1 (en) * | 2020-04-23 | 2021-10-28 | Dsm Ip Assets B.V. | Organic solvent nanofiltration of 7-dehydrocholesterol or 25-hydroxy-7-dehydrocholesterol or their oh protected forms |
WO2021213984A1 (en) | 2020-04-23 | 2021-10-28 | Dsm Ip Assets B.V. | Preparation of 7-dehydrocholesterol using specific aromatic solvents |
CN113621015A (en) * | 2021-08-11 | 2021-11-09 | 浙江新和成药业有限公司 | 7-dehydrocholesterol and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4116985A (en) * | 1976-07-26 | 1978-09-26 | The Upjohn Company | Novel method for preparing cholesta-5,7-diene 3β,25-diol and derivatives thereof |
GB2114569B (en) * | 1979-09-14 | 1984-05-23 | Hoffmann La Roche | Cholestenes for use in preparing cholecalciferol derivatives |
CH644100A5 (en) * | 1979-09-14 | 1984-07-13 | Hoffmann La Roche | CHOLECALCIFEROL DERIVATIVES. |
CN101220075A (en) * | 2008-01-25 | 2008-07-16 | 北京化工大学 | Preparation method of 7-dehydrocholesterol |
-
2008
- 2008-09-29 CN CN2008101214430A patent/CN101381389B/en active Active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104910231A (en) * | 2015-05-18 | 2015-09-16 | 浙江工业大学 | 25-hydroxy-7-dehydrocholesterol synthetic method |
CN104910231B (en) * | 2015-05-18 | 2016-08-24 | 浙江工业大学 | A kind of synthetic method of 25-hydroxyl-7-DHC |
CN105131071A (en) * | 2015-07-14 | 2015-12-09 | 浙江花园生物高科股份有限公司 | Synthesis method of 25-hydroxycholesteryl acetate-7-p-toluenesulfonylhydrazone |
CN105131071B (en) * | 2015-07-14 | 2017-09-12 | 浙江花园生物高科股份有限公司 | A kind of synthetic method of the Tosylhydrazone of 25 hydroxy cholesterol acetate 7 |
CN105646632A (en) * | 2016-01-19 | 2016-06-08 | 浙江新和成股份有限公司 | Method for preparing 7-dehydrogenized cholesteryl ester from 7-tosylhydrazones-3-cholesteryl ester |
WO2021213988A1 (en) * | 2020-04-23 | 2021-10-28 | Dsm Ip Assets B.V. | Organic solvent nanofiltration of 7-dehydrocholesterol or 25-hydroxy-7-dehydrocholesterol or their oh protected forms |
WO2021213984A1 (en) | 2020-04-23 | 2021-10-28 | Dsm Ip Assets B.V. | Preparation of 7-dehydrocholesterol using specific aromatic solvents |
CN115397832A (en) * | 2020-04-23 | 2022-11-25 | 帝斯曼知识产权资产管理有限公司 | Nanofiltration of organic solvents with 7-dehydrocholesterol or 25-hydroxy-7-dehydrocholesterol or OH protected forms thereof |
CN115427424A (en) * | 2020-04-23 | 2022-12-02 | 帝斯曼知识产权资产管理有限公司 | Preparation of 7-dehydrocholesterol using specific aromatic solvents |
CN112707779A (en) * | 2020-12-26 | 2021-04-27 | 蚌埠中实化学技术有限公司 | Preparation method of vinyl cyclohexane |
CN113621015A (en) * | 2021-08-11 | 2021-11-09 | 浙江新和成药业有限公司 | 7-dehydrocholesterol and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101381389B (en) | 2011-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101381389B (en) | Chemical Synthesis of 5,7-Diene Steroids | |
CN109053625B (en) | A kind of preparation method of substituted benzothiazole C2 alkylated derivatives | |
CN100591667C (en) | N-amino-1,2-cyclopentane dicarboximide and its preparation method | |
CN106045834A (en) | Method for preparing ambrotone | |
CN103588709A (en) | Preparation method for edaravone | |
CN106946707B (en) | Polysubstituted hydrogenation indene derivative of one kind and preparation method thereof | |
CN103613568B (en) | The preparation method of a kind of Naphtonone and analogue thereof | |
CN110872211A (en) | A kind of method of synthesizing benzofluorenol compounds | |
CN108610304A (en) | A kind of two fragrant and sultam class compound synthetic methods | |
CN104016929B (en) | A kind of method for synthesizing quinazoline-4 (3H)-ketone | |
CN101781199A (en) | Chemical synthesis method of O-acylcalix[4]arene | |
CN102898328A (en) | Synthesis method of diethyl azodicarboxylate and intermediate of diethyl azodicarboxylate | |
CN102531995A (en) | 3,3'-disubstituted-3-hydroxy bis-indolinone derivative and preparation method and application thereof | |
CN106748802B (en) | A method of preparing fluorine-containing secondary amine | |
CN106187825B (en) | A kind of N, N diamides base substitute hydazone derivative and synthetic method | |
CN101220016A (en) | A method for synthesizing 4-hydroxycoumarin and derivatives thereof | |
CN108675950A (en) | A kind of synthetic method of 2- alkenyls Benzazole compounds | |
CN108840829A (en) | Preparation method of 4-aryl-1, 3, 5-triazine-2-ketone compound | |
CN107382640B (en) | The synthetic method of β-aryl propiophenone compounds | |
CN101284755B (en) | Chemical synthesis process for conjugated alkenes compounds | |
CN112441935B (en) | Synthesis method of beta-aminoketone compound | |
CN101648893A (en) | Dicyclohexyl trifluoromethanesulfonate ammonium salt and application thereof | |
CN107098844B (en) | A kind of synthetic method for the acyl indol quinoline class compound that C-5 nitro replaces | |
CN112409432B (en) | Synthesis method of exemestane | |
CN110872218B (en) | Method for synthesizing benzofluorenone compound under catalysis of Cu |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |